During the past decade, Saint Joseph's Healthcare Charlton Campus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph's Healthcare Charlton Campus" #1 sponsor was "McMaster University" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Inventiva Pharma" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph's Healthcare Charlton Campus" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph's Healthcare Charlton Campus" are "Hematoma Postoperative" (2 trials), "Lung Cancer" (2 trials), "Stage III Renal Cell Cancer AJCC v7" (2 trials), "Tranexamic Acid" (2 trials) and "Antibiotic-Associated Diarrhea" (1 trials). Many other conditions were trialed in "Saint Joseph's Healthcare Charlton Campus" in a lesser frequency.

Most popular intervention types in "Saint Joseph's Healthcare Charlton Campus" are "Drug" (5 trials), "Procedure" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Normal Saline" (2 trials), "Tranexamic acid" (2 trials), "Bio-K capsule formulation" (1 trials), "Bio-K drink" (1 trials) and "Cabozantinib S-malate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph's Healthcare Charlton Campus" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Saint Joseph's Healthcare Charlton Campus". 2 are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Saint Joseph's Healthcare Charlton Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph's Healthcare Charlton Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".